Betamethasone/calcipotriol topical spray - Lipidor
Alternative Names: AKP-02; AKP-02G2Latest Information Update: 25 Aug 2022
At a glance
- Originator Lipidor
- Class Anti-inflammatories; Antiallergics; Antipsoriatics; Corticosteroids; Cyclohexanes; Dihydroxycholecalciferols; Fluorinated steroids; Indenes; Pregnadienetriols; Vitamin D analogues
- Mechanism of Action Calcitriol receptor agonists; Glucocorticoid receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes
Highest Development Phases
- Phase III Psoriasis
Most Recent Events
- 10 Aug 2022 Lipidor reinitiates a phase III trial in Psoriasis in India (Topical, Spray) (NCT05249972)
- 27 Sep 2021 Lipidor plans a phase III trial for Psoriasis in India in the first half of 2022 (Topical)
- 27 Sep 2021 Indian Medical Products Agency approves clinical trial application for phase III trial for Psoriasis in India (Topical)